<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>NYSTATIN- nystatin tablet, film coated </strong><br>Carilion Materials Management<br></p></div>
<h1>NYSTATIN TABLETS USP 0983 Rx only
        <br><br>
</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_inv-bf0e8c99-094e-4577-9168-4d2feceb888e"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Nystatin is an antimycotic polyene antibiotic obtained from . Its structural formula:
                            <span class="Italics">Streptomyces noursei</span></p>
<div class="Figure"><img alt="Structural formula for nystatin" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=fc0cc939-3ad1-47f2-87b9-cdd91712e0db&amp;name=28415493-e4d9-4d63-a557-9ee7d9433fdd-01.jpg"></div>
<p>C H NO M.W. 926.13
                            <span class="Sub">47</span><span class="Sub">75</span><span class="Sub">17</span></p>
<p>Nystatin tablets contain the inactive ingredients: Corn Starch, Povidone, Compressible Sugar, Microcrystalline Cellulose, Sodium Starch Glycolate, Talc, Magnesium Stearate, Purified Water, and Coloring.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="i4i_clinical_pharmacology_id_inv-db4fc002-3761-451d-ab85-12bcd9ac39bd"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_inv-078c1e78-0320-4d14-b5ec-e1c851bfebd9"></a><a name="section-2.1"></a><p></p>
<h2>Pharmacokinetics</h2>
<p class="First">Gastrointestinal absorption of nystatin is insignificant. Most orally administered nystatin is passed unchanged in the stool. In patients with <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">renal insufficiency</span> receiving oral therapy with conventional dosage forms, significant plasma concentrations of nystatin may occasionally occur.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_inv-6b46b711-5b07-405e-9f4b-ac33c0550bac"></a><a name="section-2.2"></a><p></p>
<h2>Microbiology</h2>
<p class="First">Nystatin is both fungistatic and fungicidal against a wide variety of yeasts and yeast like fungi. demonstrates no significant resistance to nystatin on repeated subculture in increasing levels of nystatin; other species become quite resistant. Generally, resistance does not develop . Nystatin acts by binding to sterols in the cell membrane of susceptible species with a resultant change in membrane permeability allowing leakage of intracellular components. Nystatin exhibits no appreciable activity against bacteria, protozoa, or viruses.
                                    <span class="Italics">in vitro</span><span class="Italics"><span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">Candida</span> albicans</span><span class="Italics">in vitro</span><span class="Italics"><span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">Candida</span></span><span class="Italics">in vivo</span><span class="Italics"><span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">Candida</span></span></p>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="i4i_indications_id_inv-b530beed-7661-4a3c-9dde-4402463d4330"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Nystatin Tablets are intended for the treatment of non-esophageal mucus membrane gastrointestinal <span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">candidiasis</span>.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="i4i_contraindications_id_inv-7feeee36-bab8-43d3-88e4-775029a9585b"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Nystatin Tablets are contraindicated in patients with a history of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any of their components.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="i4i_precautions_id_inv-83af13ba-948d-415d-9b1b-58213614f4b8"></a><a name="section-5"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="i4i_precautions_general_id_inv-b6a52ba6-b017-4fcf-b7c6-53d098661e5b"></a><a name="section-5.1"></a><p></p>
<h2>General</h2>
<p class="First">This medication is not to be used for the treatment of systemic mycoses. Discontinue treatment if sensitization or irritation is reported during use.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="i4i_carcinogenesis_mutagenesis_fertility_id_inv-5266df8b-b774-4e19-a39f-061c301ba537"></a><a name="section-5.2"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">No long-term animal studies have been performed to evaluate carcinogenic potential. There also have been no studies to determine mutagenicity or whether this medication affects fertility in males or females.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="i4i_pregnancy_id_inv-05a3aa7b-4e73-49aa-a048-bed3825c7c56"></a><a name="section-5.3"></a><p></p>
<h2>Pregnancy</h2>
<div class="Section" data-sectionCode="34077-8">
<a name="i4i_teratogenic_id_inv-a461f8a4-1b10-4bb0-9b35-e8c49ceca8a7"></a><a name="section-5.3.1"></a><p></p>
<h3>Teratogenic Effects</h3>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_pregnancy_C_id_88e29bda-452f-4e6d-bbe1-5e8663b28d98"></a><a name="section-5.3.1.1"></a><p></p>
<h4>Pregnancy category C</h4>
<p class="First">Animal reproduction studies have not been conducted with nystatin. It is also not known whether nystatin can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Nystatin should be given to a pregnant woman only if clearly needed.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="i4i_nursing_mothers_id_inv-db1fd1c9-1bc6-4663-804f-236c23cbae95"></a><a name="section-5.4"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">It is not known whether nystatin is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when nystatin is administered to a nursing woman.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="i4i_adverse_effects_id_inv-856cff6f-7516-4932-af3c-e2a68d77fd92"></a><a name="section-6"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Nystatin is well tolerated even with prolonged therapy. Oral irritation and sensitization have been reported (see ).
                            <span class="Bold">PRECAUTIONS, General</span></p>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_inv-5e892dff-b577-4019-b286-b179bd6cfc69"></a><a name="section-6.1"></a><p></p>
<h2>Gastrointestinal</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">Diarrhea</span> (including one case of <span class="product-label-link" type="condition" conceptid="4318833" conceptname="Hemorrhagic diarrhea">bloody diarrhea</span>), <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="4183041" conceptname="Abdominal discomfort">gastrointestinal upset</span>/disturbances.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_inv-138d71ac-2954-4a75-8acf-9c2adb9aa46c"></a><a name="section-6.2"></a><p></p>
<h2>Dermatologic</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">Rash</span>, including <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span> has been reported rarely. <span class="product-label-link" type="condition" conceptid="141651" conceptname="Stevens-Johnson syndrome">Stevens-Johnson syndrome</span> has been reported very rarely.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_inv-ea1d1fe2-0dd5-4bef-8ca1-ec1cadade15f"></a><a name="section-6.3"></a><p></p>
<h2>Other</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">Tachycardia</span>, <span class="product-label-link" type="condition" conceptid="256717" conceptname="Bronchospasm">bronchospasm</span>, <span class="product-label-link" type="condition" conceptid="4133326" conceptname="Facial swelling">facial swelling</span>, and nonspecific <span class="product-label-link" type="condition" conceptid="442752" conceptname="Muscle pain">myalgia</span> have also been rarely reported.</p>
</div>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="i4i_overdosage_id_inv-2878c856-3207-4b2b-8d92-afe45dbedf41"></a><a name="section-7"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">Oral doses of nystatin in excess of five million units daily have caused <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span> and <span class="product-label-link" type="condition" conceptid="4183041" conceptname="Abdominal discomfort">gastrointestinal upset</span>. There have been no reports of serious toxic effects of <span class="product-label-link" type="condition" conceptid="4105019" conceptname="Superimposed infection">superinfections</span> (see ).
                            <span class="Bold">CLINICAL</span><span class="Bold">PHARMACOLOGY, Pharmacokinetics</span></p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_dosage_admin_id_inv-8bc0ce8d-c724-4343-8062-606b6891d01c"></a><a name="section-8"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">The usual therapeutic dosage is one to two tablets (500,000 to 1,000,000 units nystatin) three times daily. Treatment should generally be continued for at least 48 hours after clinical cure to prevent relapse.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="i4i_how_supplied_id_inv-621ab9d9-85c1-4a86-9574-ff15a18d0151"></a><a name="section-9"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">NDC:68151-1487-0 in a PACKAGE of 1 TABLET, FILM COATEDS</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_68d19f8a-c2eb-4db8-92f5-c5aba0f7ce6b"></a><a name="section-10"></a><p></p>
<h1>Nystatin 500,000 units</h1>
<div class="Figure"><img alt="Label Image" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=fc0cc939-3ad1-47f2-87b9-cdd91712e0db&amp;name=68151-1487.jpg"></div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_d0f60227-be77-4714-96d1-e54f2c9df20b"></a><a name="section-10.1"></a><p></p>
<h2>Nystatin Tablets USP 500,000 units (Oral) 100 Label Text</h2>
<p class="First">0093- -01
                                    <span class="Bold">NDC</span><span class="Bold">0983</span></p>
<p><span class="Bold">NYSTATIN</span><br><span class="Bold">Tablets USP</span><br><span class="Bold">500,000 units (oral)</span></p>
<p><span class="Bold">Rx only</span></p>
<p><span class="Bold">100 TABLETS</span></p>
<p><span class="Bold">TEVA</span></p>
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>NYSTATIN 		
					</strong><br><span class="contentTableReg">nystatin tablet, film coated</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:68151-1487(NDC:0093-0983)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>NYSTATIN</strong> (NYSTATIN) </td>
<td class="formItem">NYSTATIN</td>
<td class="formItem">500000 [USP'U]</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>STARCH, CORN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POVIDONE K29/32</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CELLULOSE, MICROCRYSTALLINE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM STARCH GLYCOLATE TYPE A POTATO</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>TALC</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>ISOPROPYL ALCOHOL</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">BROWN</td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">ROUND</td>
<td class="formLabel">Size</td>
<td class="formItem">10mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">93;983</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:68151-1487-0</td>
<td class="formItem">1  in 1 PACKAGE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA062506</td>
<td class="formItem">09/30/1990</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Carilion Materials Management
							(079239644)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>Carilion Materials Management (079239644)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Carilion Materials Management</td>
<td class="formItem"></td>
<td class="formItem">079239644</td>
<td class="formItem">REPACK(68151-1487)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 10/2013<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>23972e7f-2313-4524-b554-b930e51fed92</div>
<div>Set id: fc0cc939-3ad1-47f2-87b9-cdd91712e0db</div>
<div>Version: 3</div>
<div>Effective Time: 20131015</div>
</div>
</div> <div class="DistributorName">Carilion Materials Management</div></p>
</body></html>
